Childhood Asthma Control Assessment

Childhood asthma control assessment encompasses the systematic evaluation of symptom burden, lung function and treatment adherence in paediatric patients with asthma. Accurate assessment is critical for guiding therapy, minimising exacerbations and improving quality of life. In clinical practice and research, control is gauged by combining patient- or caregiver-reported questionnaires, objective measures such as spirometry and biomarkers of airway inflammation, and standardised clinical criteria. The heterogeneity of childhood asthma phenotypes, varying age-related perceptions of symptoms and the influence of environmental and socioeconomic factors all contribute to the challenge of selecting robust, reliable tools. Contemporary approaches strive to balance sensitivity to change, cultural adaptability and ease of use in diverse settings, from primary care to school-based screening programmes. Innovations in digital monitoring, integration of patient-reported outcome measures and refined interpretation of lung function indices are shaping a more personalised control assessment framework with global applicability.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Childhood Asthma Control Assessment publication trend

The graph below shows the total number of articles in childhood asthma control assessment across all publications each year (not limited to Nature Index journals).

Technical terms

Asthma Control Test (ACT): A five-item patient-reported measure of symptom frequency and activity limitation over the preceding four weeks, yielding a score that categorises control.

Childhood Asthma Control Test (c-ACT): An extension of the ACT combining child and caregiver reports, validated for children aged 4–11 years to assess recent symptom control.

Asthma Control Questionnaire (ACQ): A tool comprising six or seven items including symptoms, reliever use and lung function, used to quantify asthma control in clinical and research contexts.

Royal College of Physicians’ three questions (RCP3Q): A brief clinician-administered set of questions addressing symptom frequency, nocturnal waking and activity limitation to screen for uncontrolled asthma.

Global Initiative for Asthma (GINA): An international guideline programme providing evidence-based recommendations for the diagnosis and management of asthma, including standard definitions of control.

Minimally Important Difference (MID): The smallest change in a questionnaire score that patients perceive as beneficial, guiding interpretation of treatment effects.

References

1. A systematic review of questionnaires measuring asthma control in children in a primary care population. npj Primary Care Respiratory Medicine (2023).
2. Development and equivalence of new faces for inclusion in the Childhood Asthma Control Test (C-ACT) response scale. Journal of Patient-Reported Outcomes (2021).
3. An exploratory study on the validity and reliability of the Greek translation of Juniper’s Asthma Control Questionnaire in pediatric patients in Greece. Exploration of Asthma & Allergy (2023).